Generics - Diabetes, Biotechnology

Filter

Current filters:

DiabetesBiotechnology

Popular Filters

US nephrologists expect rapid adoption of USA's first biosimilars - epoetin alfa

09-10-2012

More than 60% of surveyed nephrologists in the USA expect to begin prescribing biosimilar epoetin alfa…

BiotechnologyDiabetesGenericsMarkets & MarketingNephrology and Hepatology

Most US and European physicians believe automatic substitution of biosimilars is a bad idea

05-09-2012

Specialist physicians surveyed in the USA and Europe are generally opposed to pharmacy-level automatic…

BiotechnologyDiabetesEuropeGenericsMarkets & MarketingNorth America

COMPANY SPOTLIGHT

Menarini

Back to top